When examining Ctdnep1-cKO NPC tumorigenic cells at the late stage (DIC 60), we found that, despite upregulation of MYC targets, the p53 pathway was downregulated compared with wild-type cerebellar NPCs (Fig. 5e). This evidence concerns the gene MYC and nasopharyngeal carcinoma.